Protagonist Therapeutics, Inc. (PTGX)

NASDAQ: PTGX · IEX Real-Time Price · USD

34.59

-0.61 (-1.73%)

At close: Jul 2, 2024, 4:00 PM

34.57

-0.02 (-0.06%)

After-hours: Jul 2, 2024, 7:00 PM EDT

Protagonist Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2014
Revenue	60	26.58	27.36	28.63	0.23	Upgrade
Revenue Growth (YoY)	125.73%	-2.84%	-4.44%	12293.07%	-99.25%	Upgrade
Gross Profit	60	26.58	27.36	28.63	0.23	Upgrade
Selling, General & Admin	33.49	31.74	27.2	18.64	15.75	Upgrade
Research & Development	120.16	126.22	126.01	74.51	65	Upgrade
Operating Expenses	153.65	157.95	153.2	93.14	80.75	Upgrade
Operating Income	-93.65	-131.37	-125.85	-64.52	-80.52	Upgrade
Interest Expense / Income	0	0	0	0.6	0.17	Upgrade
Other Expense / Income	-14.7	-3.98	-0.29	-0.27	-2.81	Upgrade
Pretax Income	-78.96	-127.39	-125.55	-64.85	-77.88	Upgrade
Income Tax	0	0	0	1.31	-0.69	Upgrade
Net Income	-78.96	-127.39	-125.55	-66.15	-77.19	Upgrade
Shares Outstanding (Basic)	57	49	46	34	26	Upgrade
Shares Outstanding (Diluted)	57	49	46	34	26	Upgrade
Shares Change	15.74%	5.87%	34.67%	32.84%	15.78%	Upgrade
EPS (Basic)	-1.39	-2.60	-2.71	-1.92	-2.98	Upgrade
EPS (Diluted)	-1.39	-2.60	-2.71	-1.92	-2.98	Upgrade
Free Cash Flow	-70.85	-108.93	-108.97	-72.96	-42.49	Upgrade
Free Cash Flow Per Share	-1.25	-2.22	-2.35	-2.12	-1.64	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-156.09%	-494.24%	-460.01%	-225.36%	-34857.58%	Upgrade
Profit Margin	-131.59%	-479.26%	-458.94%	-231.07%	-33414.29%	Upgrade
Free Cash Flow Margin	-118.08%	-409.81%	-398.31%	-254.84%	-18395.67%	Upgrade
EBITDA	-75.64	-124.02	-122.78	-61.52	-75.19	Upgrade
EBITDA Margin	-126.07%	-466.59%	-448.79%	-214.91%	-32547.62%	Upgrade
Depreciation & Amortization	3.31	3.37	2.78	2.72	2.52	Upgrade
EBIT	-78.96	-127.39	-125.55	-64.25	-77.71	Upgrade
EBIT Margin	-131.59%	-479.26%	-458.94%	-224.42%	-33640.26%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).